Clinical Trial Update: A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia [Phase 3]

View source ↗

Summary

Ionis Pharmaceuticals reports that the Phase 3 trial of olezarsen (ISIS 678354) in adults with severe hypertriglyceridemia has completed. The update provides th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Olezarsen (olezarsen)

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Severe Hypertriglyceridemia | Phase 3 | Status: COMPLETED